Unione Europea -
italiano -
EMA (European Medicines Agency)
abiraterone mylan
mylan ireland limited - abiraterone acetato - neoplasie prostatiche - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
Unione Europea -
italiano -
EMA (European Medicines Agency)
abiraterone accord
accord healthcare s.l.u. - abiraterone acetato - neoplasie prostatiche - terapia endocrina - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
Unione Europea -
italiano -
EMA (European Medicines Agency)
abiraterone krka
krka, d.d., novo mesto - abiraterone acetato - neoplasie prostatiche - terapia endocrina - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
abiraterone bluepharma
bluepharma industria farmaceutica s.a. - abiraterone acetato - abiraterone acetato
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
abiraterone sandoz
sandoz s.p.a. - abiraterone acetato - abiraterone acetato
Unione Europea -
italiano -
EMA (European Medicines Agency)
ulipristal acetate gedeon richter
gedeon richter plc. - ulipristal acetato - leiomioma - ormoni sessuali e modulatori del sistema genitale, - ulipristal acetato è indicato per un corso del trattamento di pre-operatorio il trattamento di moderata a gravi sintomi di fibromi uterini negli adulti le donne in età riproduttiva. ulipristal acetato è indicato per intermittente trattamento di moderata a gravi sintomi di fibromi uterini negli adulti le donne in età riproduttiva che non sono eleggibili per la chirurgia.
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
ranitidina ibirn 20cpr riv 150
i.bir.n srl ist.biot.nazionale - ranitidina cloridrato - compresse rivestite - 20 compresse in blister al/al da 150 mg
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
ulipristal aristo
aristo pharma gmbh - ulipristal - ulipristal
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
abiraterone doc
doc generici srl - abiraterone acetato - abiraterone acetato